Rebate agreements for Peginterferon beta 1a medicines 2026-20

Summary

The tender concerns an open-house agreement for Peginterferon beta 1a medicines. Techniker Krankenkasse intends to conclude rebate agreements with all suitable pharmaceutical companies under Section 130a(8) of the German Social Code V. There are no individual negotiations; uniform terms apply. No exclusivity is granted. The contract term is up to 24 months from 01.08.2026 and ends no later than 31.07.2028, or earlier if patent protection/market exclusivity ends first. Further details must be checked in the participation and contract documents.